DNA fingerprint may predict cancer immunotherapy success
NCT ID NCT05515796
First seen Apr 12, 2026 · Last updated May 20, 2026 · Updated 8 times
Summary
This study tested whether a special DNA test (epigenetics multi-omics sequencing) can predict how well immunotherapy works for people with stomach or rectal cancer. 189 patients took part. The goal was to see if the test could tell who would have a complete response to treatment. This is a knowledge-gathering study, not a direct treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Army Medical Center
Chongqing, Other (Non U.s.), 400000, China
Conditions
Explore the condition pages connected to this study.